Thriva and Tasso Partner to Revolutionize Blood Testing for Needle Phobia Sufferers
核心洞察
UK-based Thriva (搜索) has partnered with medical device manufacturer Tasso (搜索) to develop needle-free blood testing technology, addressing a condition affecting at least 10% of adults and up to 63% of children.
The Tasso+ (搜索) device enables painless at-home blood collection without traditional needles, allowing users to receive comprehensive health reports with personalized recommendations from GPs within 48 hours.
This collaboration aims to increase preventative healthcare access, as research indicates 40% of health service uptake in England could be prevented by addressing barriers like needle phobia (搜索).
UK-based blood testing company Thriva (搜索) has formed a strategic partnership with medical device manufacturer Tasso (搜索) to combat needle phobia (搜索) through innovative, pain-free blood testing technology. The collaboration addresses a significant healthcare barrier that affects approximately 10% of adults and prevents many from seeking essential preventative care.
Addressing a Widespread Healthcare Barrier
Needle phobia (搜索) represents a substantial obstacle to healthcare access, with an estimated 10% of adults avoiding vaccinations and medical procedures due to fear of needles. The condition is even more prevalent among younger populations, affecting up to 63% of children and 25% of young adults.
These fears stem from various psychological and physiological factors, including vasovagal responses (fainting due to blood pressure drops), hyperalgesia (heightened pain sensitivity), and traumatic past experiences with needles.
Harriet Evans, a 24-year-old from the Lake District who suffers from needle phobia (搜索), describes her experience: "I've been scared of needles for as long as I can remember. I'm not entirely sure what caused it, but I think it might stem from an operation I had as a child. There were a lot of blood tests, and I remember them sticking all sorts of things in my arms and hands."
How the Needle-Free Technology Works
The Tasso+ (搜索) device represents a significant advancement in blood collection methodology. Unlike traditional methods requiring venipuncture or finger pricks, this technology:
- Uses a gentle application process where the device is placed against the skin
- Collects whole liquid blood samples through advanced needle-free lancet technology
- Completes the collection process in approximately 5 minutes
- Enables sample analysis with results delivered within 48 hours
Dr. Vishal Shah, Chief Medical Officer at Thriva (搜索), explains: "By combining Thriva's technology and expertise with Tasso (搜索)'s innovative blood collection device, we empower people to understand what's happening inside their bodies through regular, painless testing. This approach helps individuals optimize their health for both immediate and long-term well-being."
Comprehensive Health Monitoring
Thriva (搜索)'s blood testing services screen for multiple health markers, including:
- Cardiovascular health
- Liver function
- Hormonal balance
- Kidney function
- Iron levels
- Nutritional deficiencies
After testing, users receive a comprehensive report from a GP with personalized lifestyle recommendations. The service also offers the option to discuss results with a doctor or share the report with their primary care physician.
Patient-Centered Approach
The at-home testing model provides users with greater control over their healthcare experience—a particularly valuable benefit for those with needle phobia (搜索).
"The main benefit of home testing kits is that you're empowered to do things in your own time," says Evans. "When I go to the doctor, I feel like I have to do the blood test then and there. With home tests, you decide when you're ready. Taking back control is a big part of tackling a phobia."
This user-centered approach allows individuals to create comfortable testing environments on their own terms. Evans describes her experience: "I decided which day I wanted to do the test, I had a cup of tea and a snack, put the TV on, and did it one step at a time. I put the patch on first, decided when to click it, felt the tiniest needle, and then didn't feel anything. It was over before I knew it."
Broader Public Health Implications
Research by the British Medical Association suggests that 40% of health service uptake in England could be prevented by addressing drivers of ill-health. By removing barriers to preventative care, this technology has potential implications beyond individual patient comfort.
Erwin Berthier, Co-founder of Tasso (搜索), emphasizes this broader mission: "At Tasso, we're passionate about making high-quality blood testing easy and accessible to drive personalized health solutions. Our Tasso+ (搜索) device is designed to eliminate the barriers that keep people from getting the important health information they need."
Regular Monitoring for Proactive Health Management
The Thriva (搜索)-Tasso (搜索) partnership encourages regular health monitoring, typically recommending testing every 3-6 months. This frequency enables users to track health trends over time and make proactive adjustments based on their results.
By making blood testing more accessible and less intimidating, the companies aim to shift healthcare from a reactive model to a preventative approach, potentially reducing the burden of late-stage disease management and improving overall public health outcomes.